Amanote Research
Register
Sign In
Chronic Myeloid Leukemia Stem Cells Possess Multiple Unique Features of Resistance to BCR-ABL Targeted Therapies
Leukemia
- United Kingdom
doi 10.1038/sj.leu.2404609
Full Text
Open PDF
Abstract
Available in
full text
Categories
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
Date
March 1, 2007
Authors
X Jiang
Y Zhao
C Smith
M Gasparetto
A Turhan
A Eaves
C Eaves
Publisher
Springer Science and Business Media LLC
Related search
BCR-ABL-transformed GMP as Myeloid Leukemic Stem Cells
Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
Inhibitory Effects of Omacetaxine on Leukemic Stem Cells and BCR-ABL-induced Chronic Myeloid Leukemia and Acute Lymphoblastic Leukemia in Mice
Leukemia
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
Combined Inhibition of MDM2 and BCR-Abl Tyrosine Kinase Targets Chronic Myeloid Leukemia Stem/Progenitor Cells in a Murine Model
Haematologica
Hematology
Acute Myeloid Leukemia With BCR/ABL Fusion Chimera
Indian Journal of Hematology and Blood Transfusion
Hematology
Imatinib Mesylate Resistance Through BCR-ABL Independence in Chronic Myelogenous Leukemia
Cancer Research
Cancer Research
Oncology
Chronic Myeloid Leukemia With an E1a3 BCR-ABL Fusion Protein: Transformation to Lymphoid Blast Crisis
Biomarker Research
Biochemistry
Molecular Medicine
Clinical Biochemistry
Contribution of BCR-ABL Kinase Domain Mutations to Imatinib Mesylate Resistance in Philadelphia Chromosome Positive Malaysian Chronic Myeloid Leukemia Patients
Hematology Reports
Hematology
Management of Chronic Myeloid Leukemia With BCR/ABL Inhibitors: Current Status and Future Perspectives
Clinical Medicine Insights: Therapeutics
Medicine
Pharmacology
Pharmaceutical Science
Incidence and Outcome of BCR‐ABL Mutated Chronic Myeloid Leukemia Patients Who Failed to Tyrosine Kinase Inhibitors
Cancer Medicine
Cancer Research
Nuclear Medicine
Radiology
Imaging
Oncology
